Private class action lawsuits play a significant role in the vindication and development of U.S. antitrust law. But what are attorneys and courts to do when they know there's an injured class, but are not quite sure who's in it and who's not? Tram Nguyen, Ph.D., an economist and Managing Principal at Edgeworth Economics, joins Alicia Downey and Matt Reynolds to discuss how economic analysis can help overcome issues with ascertaining class membership, particularly in the context of the pharmaceutical industry. Listen to this episode to learn more about not only the "ascertainability" requirement in class action litigation but also Tram's favorite beach destinations.

With special guest:

Tram Nguyen, Ph.D., Managing Principal, Edgeworth Economics

Related Links:

George Korenko & Tram Nguyen, Finding Uninjured Consumers In Drug Antitrust Class Actions 

George Korenko & Tram Nguyen, Lamictal and the Myth of “Generic” “Pay-for-Delay” Cases 

George Korenko & Tram Nguyen, Don’t Count Out Numerosity 

Hosted by:

Matthew Reynolds, Huth Reynolds LLP and Alicia Downey, Downey Law LLC